美银证券发表报告指，康方生物(09926.HK) 卡度尼利单抗cadonilimab逆季节性录得按月增长。康方生物2月样本药品销售额为7,130万元人民币(下同)，按年增长319.6%。其中卡度尼利单抗销售额为4,430万元，按年增长249.5%，按月增长9.6%，在农历假期期间仍实现正环比增长。ivonescimab月销售额达2,660万元，持续放量，按年增长517.4%。维持康方生物“买入”...
Source Link美银证券发表报告指，康方生物(09926.HK) 卡度尼利单抗cadonilimab逆季节性录得按月增长。康方生物2月样本药品销售额为7,130万元人民币(下同)，按年增长319.6%。其中卡度尼利单抗销售额为4,430万元，按年增长249.5%，按月增长9.6%，在农历假期期间仍实现正环比增长。ivonescimab月销售额达2,660万元，持续放量，按年增长517.4%。维持康方生物“买入”...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.